Ocular Therapeutix, Inc. Financial Ratios — OCUL Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-59.94	-58.86	-42.17	-48.26	-97.24	-93.37	-113.81	-91.39	-2.81	-40.11	-40.23	-54.51	-42.01
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	30	- -	88.21	81.77	76.52	76.24	76.63	45	88.03	89.88	91.18	90.96	91.17	87.35
EBITDA Margin (%)	-132,670	- -	-3,438.73	-2,139.6	-2,249.34	-3,135.62	-2,855.88	-1,970	-345.19	-173.74	-148.65	-135.86	-263.63	-511.43
Operating Margin (%)	-136,710	- -	-3,509.59	-2,182.69	-2,296.03	-3,220.12	-2,970.75	-2,029.86	-361.13	-179.3	-152.74	-140.96	-269.57	-519.75
Incremental Operating Margin (%)	- -	-7,680	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-140,930	- -	-3,710.88	-2,271.31	-2,369	-3,296.2	-3,013.97	-2,043.34	-894.31	-15.06	-137.95	-138.14	-303.67	-511.9
Profit Margin (%)	-140,930	- -	-3,710.88	-2,271.31	-2,369	-3,296.2	-3,013.97	-2,043.34	-894.31	-15.06	-137.95	-138.14	-303.67	-511.9
Net Income to Common Margin (%)	-141,280	- -	-3,712.31	-2,271.31	-2,369	-3,296.2	-3,013.97	-2,043.34	-894.31	-15.06	-137.95	-138.14	-303.67	-511.9
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.25	0.2	0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4	2	15	15	16	18	25	59	58	59	64	83	76	77
ST Debt	2	2	1	- -	2	6	- -	1	10	2	2	2	2	3
LT Debt	2	1	14	15	14	12	25	58	49	57	63	82	74	74
Total Debt/EBITDA	-0.31	-0.2	-0.56	-0.41	-0.37	-0.3	-0.44	-0.71	-0.97	-0.78	-0.84	-1.05	-0.45	-0.29
Net Debt/EBITDA	1.49	1.2	0.85	0.41	0.41	0.39	0.52	0.06	2.97	1.49	0.63	1.52	1.93	2.51
Total Debt/EBIT	-0.3	-0.19	-0.55	-0.4	-0.36	-0.29	-0.42	-0.69	-0.93	-0.76	-0.82	-1.01	-0.44	-0.29
Net Debt/EBIT	1.45	1.17	0.83	0.41	0.4	0.38	0.5	0.06	2.84	1.44	0.61	1.47	1.88	2.47
EBITDA to Interest Expense	-35.19	-28.34	-23.72	-21.72	-25.26	-31.87	-32.68	-13.65	-8.88	-11.34	-10.9	-7	-12.37	-22.45
EBITDA-CapEx/Interest Expense	-35.73	-29.22	-24.85	-22.75	-26.41	-36.23	-33.77	-14.02	-9	-11.51	-11.43	-7.54	-12.47	-23.46
EBIT to Interest Expense	-36.26	-29.26	-24.21	-22.16	-25.79	-32.73	-34	-14.06	-9.29	-11.7	-11.2	-7.27	-12.65	-22.82
Interest Expense	- -	- -	1	2	2	2	2	6	7	7	7	11	14	12
Common Equity/Total Assets	-187.71	-317.46	-114.37	-117.11	-232.02	-428.03	-406.94	-487.19	-205.93	-266.39	-413.18	-276.75	-194.58	-143.18
Long-Term Debt/Equity (%)	- -	- -	23.02	17.05	27.1	47.7	69.1	- -	64.12	65.18	177.18	89.76	23.42	11.33
Long-Term Debt/Capital (%)	10.07	-1.12	-18.12	-13.41	-8.91	-5.69	-9.1	-17.95	-10.15	-11.78	-11.34	-13.32	-9.06	-6.87
Long-Term Debt/Total Assets (%)	8.93	3.4	17.28	13.85	18.81	22.5	33.94	73.94	18.63	28	41.99	32.45	16.13	9.18
Total Debt/Equity (%)	-8.72	-4.13	25.33	17.05	30.08	68.9	69.1	-1,634.79	76.8	67.03	181.7	91.5	24.03	11.76
Total Debt/Capital (%)	18.13	-4.21	-19.94	-13.41	-9.89	-8.22	-9.1	-18.3	-12.15	-12.12	-11.63	-13.58	-9.3	-7.13
Total Debt/Total Assets (%)	16.08	12.83	19.01	13.85	20.87	32.5	33.94	75.37	22.32	28.79	43.06	33.08	16.55	9.53
Net Debt to Equity	42.46	25.3	-38.38	-17.31	-33.25	-89.96	-81.6	141.18	-234.61	-128.1	-136.5	-132.65	-102.62	-101.74
Net Debt/Capital (%)	1,384.81	19.84	20.12	10.72	9.05	9.02	8.97	1.35	25.18	17.32	7.37	14.92	26.8	36.64
EBITDA	-13	-12	-27	-37	-42	-60	-57	-83	-60	-76	-77	-79	-168	-266
EBITDA-CapEx	-13	-13	-28	-39	-44	-69	-59	-86	-61	-77	-80	-85	-169	-278
Operating Income (Loss)	-14	-13	-27	-38	-43	-62	-59	-86	-63	-78	-79	-82	-172	-270

Liquidity (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	6.86	5.24	12.74	19.54	8.21	3.09	5.9	4.53	8.55	6.23	3.26	5.61	9.48	14.51
Current Ratio	6.98	5.39	12.97	19.89	8.42	3.23	6.14	5	9.23	7.26	4.13	6.66	10.66	15.39
Quick Ratio	6.88	5.32	12.79	19.57	8.24	3.11	5.92	4.74	9.01	7.04	3.94	6.36	10.26	15.11
CFO/Avg Current Liab	- -	-3.71	-4.45	-6	-4.97	-4.65	-4.36	-7.32	-2.77	-2.47	-2.06	-2.12	-3.53	-4.45
Common Equity/Total Assets	-187.71	-317.46	-114.37	-117.11	-232.02	-428.03	-406.94	-487.19	-205.93	-266.39	-413.18	-276.75	-194.58	-143.18
Long-Term Debt/Equity (%)	- -	- -	23.02	17.05	27.1	47.7	69.1	- -	64.12	65.18	177.18	89.76	23.42	11.33
Long-Term Debt/Capital (%)	10.07	-1.12	-18.12	-13.41	-8.91	-5.69	-9.1	-17.95	-10.15	-11.78	-11.34	-13.32	-9.06	-6.87
Long-Term Debt/Total Assets (%)	8.93	3.4	17.28	13.85	18.81	22.5	33.94	73.94	18.63	28	41.99	32.45	16.13	9.18
Total Debt/Equity (%)	-8.72	-4.13	25.33	17.05	30.08	68.9	69.1	-1,634.79	76.8	67.03	181.7	91.5	24.03	11.76
Total Debt/Capital (%)	18.13	-4.21	-19.94	-13.41	-9.89	-8.22	-9.1	-18.3	-12.15	-12.12	-11.63	-13.58	-9.3	-7.13
Total Debt/Total Assets (%)	16.08	12.83	19.01	13.85	20.87	32.5	33.94	75.37	22.32	28.79	43.06	33.08	16.55	9.53
CFO/Total Liabilities	-17.5	-16.08	-105.12	-162.87	-148.28	-172.36	-132.44	-94.18	-28.83	-56.08	-52.32	-43.64	-94.45	-133.26
CFO/CapEx	-62	-32.67	-16.27	-18.98	-17.72	-6.12	-26.06	-34.66	-63.68	-54.9	-16.04	-11.54	-104.56	-17.06
Altman's Z-Score	-3.43	-5.75	6.05	4.65	1.29	-6.37	-5.12	-8.33	1.46	-1.07	-5.25	-2.45	2.91	6.91

Working Capital (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	2.58	6.7	8.52	8.08	9.32	3.08	2.35	2.61	2.43	2.46	2.18	1.65
Days Sales Outstanding	- -	- -	141.37	54.44	42.84	45.17	39.16	118.69	155.2	140	150.48	148.34	167.73	221.45
Inventory Turnover	- -	- -	1.37	2.39	3.59	3.89	2.74	3.97	1.93	3.6	2.82	2.47	2.11	1.99
Days Inventory Outstanding	- -	- -	266.73	152.75	101.76	93.85	133.05	91.92	188.81	101.52	129.6	147.87	173.38	183.33
Accounts Payable Turnover	- -	- -	0.24	0.2	0.21	0.16	0.17	0.98	0.78	1.22	1.08	1.18	1.49	1.7
Accounts Payable Turnover Days	- -	- -	1,516.22	1,866.63	1,761.43	2,227.2	2,130.04	371.5	468.16	299.09	336.81	309.33	245.73	214.18
Cash Conversion Cycle	- -	- -	-1,108.12	-1,659.44	-1,616.83	-2,088.18	-1,957.83	-160.89	-124.14	-57.56	-56.73	-13.11	95.38	190.6
Inventory to Cash Days	- -	- -	-125.36	-98.31	-58.91	-48.67	-93.89	26.77	-33.61	38.48	20.88	0.47	-5.65	38.11
Inventories	- -	- -	- -	- -	- -	- -	- -	1	1	1	2	2	3	4
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	2
Finished Goods	- -	- -	- -	- -	- -	- -	- -	1	1	- -	1	1	1	2
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	251	218	208	128	152	179	1,258	532	216	356	1,352	2,273
- Cash & Cash Equivalents	24	18	37	31	33	42	54	54	228	164	102	196	392	737
+ Preferred Equity and Hybrid Capital	66	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	2	15	15	16	18	25	59	58	59	64	83	76	77
Enterprise Value	46	-15	191	128	155	105	122	184	1,088	427	178	244	1,035	1,613
Total Capital	22	-58	-75	-114	-158	-219	-272	-324	-481	-487	-553	-614	-815	-1,080
Total Debt/Capital (%)	18.13	-4.21	-19.94	-13.41	-9.89	-8.22	-9.1	-18.3	-12.15	-12.12	-11.63	-13.58	-9.3	-7.13
Total Debt / EV	0.09	-0.16	0.08	0.12	0.1	0.17	0.2	0.32	0.05	0.14	0.36	0.34	0.07	0.05
EV/Sales	4,603.4	- -	246.88	73.15	82.25	54.46	61.52	43.47	62.52	9.82	3.46	4.17	16.25	31.05
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	251	218	208	128	152	179	1,258	573	232	382	1,352	2,273
Diluted Enterprise Value	46	-15	228	202	190	105	122	184	1,088	467	194	269	1,035	1,613
EV per Share	15.59	- -	17.89	5.51	6.25	3.63	3.21	4.06	17.91	5.59	2.32	3.05	6.54	8.61
TTM Sales	- -	- -	1	2	2	2	2	4	17	44	51	58	64	52
TTM EBITDA	-13	-12	-27	-37	-42	-60	-57	-83	-60	-76	-77	-79	-168	-266
TTM Operating Income	-14	-13	-27	-38	-43	-62	-59	-86	-63	-78	-79	-82	-172	-270
TTM Cash Flow to Firm	-12	-12	-19	-32	-32	-49	-47	-71	-47	-59	-53	-59	-121	-193
TTM Free Cash Flow to Firm	-12	-12	-18	-30	-30	-40	-46	-69	-46	-58	-49	-53	-120	-181

Multiples (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-13.03	-6.81	-6.47	-3.04	-3.2	-2.37	-23.86	-8.9	-4.16	-5.95	-10.13	-11.79
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	46	-15	191	128	155	105	122	184	1,088	427	178	244	1,035	1,613
Low Price	- -	- -	11.9	6.74	4.04	3.3	3.55	2.35	3.78	6.02	2.57	2	3.76	5.79
EV/Sales	4,603.4	- -	246.88	73.15	82.25	54.46	61.52	43.47	62.52	9.82	3.46	4.17	16.25	31.05
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-5.93	-12.86	-4.35	-3.36	-3.86	-2.05	-3.4	-154.9	-4.78	-4.38	-6.41	-7.01
Price/Earnings High	- -	- -	-9	-25.84	-8.05	-5.36	-5.26	-2.91	-9.49	-276.05	-7.99	-7.87	-9.63	-11.58
Price/Earnings Low	- -	- -	-4.42	-3.94	-2.24	-1.5	-2.26	-1.23	-1.47	-70.18	-2.78	-1.97	-3.08	-4.08
Price/Book Value	- -	- -	-2.8	-1.69	-1.19	-0.54	-0.51	-0.47	-2.33	-0.98	-0.35	-0.51	-1.52	-1.96
Price/Book Value Average	- -	- -	-1.9	-3.96	-1.12	-0.9	-0.78	-0.46	-0.98	-1.86	-0.55	-0.51	-1.39	-1.61
Price/Book Value High	- -	- -	-2.88	-7.95	-2.07	-1.43	-1.06	-0.66	-2.74	-3.31	-0.92	-0.91	-2.09	-2.66
Price/Book Value Low	- -	- -	-1.42	-1.21	-0.58	-0.4	-0.46	-0.28	-0.43	-0.84	-0.32	-0.23	-0.67	-0.94
Price/Tangible Book Value	- -	- -	4.27	2.43	3.99	4.9	4.23	-49.26	16.53	6.05	6.11	3.91	4.29	3.47
Price/Tangible Book Value Average	- -	- -	2.9	5.71	3.74	8.14	6.46	-48.85	6.96	11.53	9.6	3.88	3.93	2.85
Price/Tangible Book Value High	- -	- -	4.39	11.47	6.92	12.99	8.79	-69.22	19.4	20.56	16.04	6.97	5.91	4.7
Price/Tangible Book Value Low	- -	- -	2.16	1.75	1.93	3.64	3.77	-29.31	3.01	5.23	5.58	1.75	1.89	1.66
Price/Sales	- -	- -	324.55	124.46	110.08	66.69	76.23	42.31	72.26	12.23	4.2	6.09	21.21	43.75
Price/Sales Average	- -	- -	220.18	292.2	103.07	110.67	116.42	41.95	30.43	23.32	6.6	6.05	19.45	35.88
Price/Sales High	- -	- -	334.07	586.95	190.69	176.69	158.53	59.44	84.83	41.56	11.02	10.87	29.26	59.25
Price/Sales Low	- -	- -	164.21	89.59	53.13	49.45	67.99	25.17	13.18	10.57	3.84	2.72	9.34	20.87
Price/Cash Flow	- -	- -	-12.22	-6.45	-6.11	-2.54	-3.08	-2.31	-23.48	-8.12	-3.62	-5.07	-10.04	-11.09
Price/Cash Flow Average	- -	- -	-8.29	-15.15	-5.72	-4.22	-4.71	-2.29	-9.89	-15.48	-5.7	-5.03	-9.2	-9.1
Price/Cash Flow High	- -	- -	-12.58	-30.44	-10.58	-6.73	-6.41	-3.24	-27.57	-27.6	-9.52	-9.05	-13.84	-15.02
Price/Cash Flow Low	- -	- -	-6.19	-4.65	-2.95	-1.88	-2.75	-1.37	-4.28	-7.02	-3.31	-2.27	-4.42	-5.29
Price/Free Cash Flow Average	- -	- -	-8.84	-16	-6.06	-5.04	-4.89	-2.35	-10.05	-16.96	-6.53	-5.91	-9.29	-9.67
Price/Free Cash Flow High	- -	- -	-13.41	-32.13	-11.22	-8.05	-6.66	-3.34	-28.01	-30.23	-10.91	-10.62	-13.98	-15.96
Price/Free Cash Flow Low	- -	- -	-6.59	-4.9	-3.13	-2.25	-2.86	-1.41	-4.35	-7.69	-3.8	-2.66	-4.46	-5.62
EV/Sales Average	4,603.4	- -	191	283.34	93.9	98.44	101.71	43.11	20.68	20.91	5.86	4.13	14.49	23.18
EV/Sales High	4,603.4	- -	304.89	578.08	181.53	164.45	143.82	60.6	75.08	39.15	10.28	8.95	24.29	46.55
EV/Sales Low	4,603.4	- -	135.03	80.73	43.97	37.22	53.28	26.33	3.43	8.15	3.1	0.8	4.37	8.16
EV/EBITDA Average	-3.47	1.2	-5.55	-13.24	-4.17	-3.14	-3.56	-2.19	-5.99	-12.03	-3.94	-3.04	-5.5	-4.53
EV/EBITDA High	-3.47	1.2	-8.87	-27.02	-8.07	-5.24	-5.04	-3.08	-21.75	-22.53	-6.92	-6.59	-9.21	-9.1
EV/EBITDA Low	-3.47	1.2	-3.93	-3.77	-1.95	-1.19	-1.87	-1.34	-0.99	-4.69	-2.08	-0.59	-1.66	-1.6
EV/EBIT Average	-3.37	1.17	-5.44	-12.98	-4.09	-3.06	-3.42	-2.12	-5.73	-11.66	-3.83	-2.93	-5.37	-4.46
EV/EBIT High	-3.37	1.17	-8.69	-26.48	-7.91	-5.11	-4.84	-2.99	-20.79	-21.83	-6.73	-6.35	-9.01	-8.96
EV/EBIT Low	-3.37	1.17	-3.85	-3.7	-1.91	-1.16	-1.79	-1.3	-0.95	-4.55	-2.03	-0.57	-1.62	-1.57
Last Price	- -	- -	23.52	9.37	8.37	4.45	3.98	3.95	20.7	6.97	2.81	4.46	8.54	12.14
High Price	- -	- -	24.21	44.19	14.5	11.79	8.28	5.55	24.3	23.68	7.38	7.96	11.78	16.44
Enterprise Value Average	46	-15	147	496	177	189	202	182	360	910	302	241	923	1,204
Enterprise Value High	46	-15	235	1,012	343	316	286	256	1,307	1,704	529	523	1,548	2,418
Enterprise Value Low	46	-15	104	141	83	72	106	111	60	355	160	47	279	424

Shares Outstanding	21	21	21	25	25	30	42	50	76	77	77	115	158	216
Diluted Weighted Avg Shares	3	3	11	23	25	29	38	45	61	82	83	86	158	187
Basic Weighted Avg Shares	3	3	11	23	25	29	38	45	61	76	77	80	158	187
Revenue per Share	- -	- -	0.07	0.08	0.08	0.07	0.05	0.09	0.29	0.57	0.67	0.73	0.4	0.28
EBITDA per Share	-4.49	-4.23	-2.49	-1.61	-1.71	-2.09	-1.49	-1.84	-0.99	-0.99	-1	-0.99	-1.06	-1.42
Operating Income per Share	-4.63	-4.37	-2.54	-1.64	-1.75	-2.15	-1.55	-1.9	-1.03	-1.02	-1.02	-1.03	-1.09	-1.44
Basic EPS, GAAP	-4.78	-4.52	-2.69	-1.71	-1.8	-2.2	-1.57	-1.91	-2.56	-0.09	-0.92	-1.01	-1.22	-1.42
Basic EPS from Cont Ops	-4.77	-4.51	-2.69	-1.71	-1.8	-2.2	-1.57	-1.91	-2.56	-0.09	-0.92	-1.01	-1.22	-1.42
Diluted EPS, GAAP	-4.78	-4.52	-2.69	-1.71	-1.8	-2.2	-1.57	-1.91	-2.56	-0.08	-0.86	-0.94	-1.22	-1.42
Diluted EPS from Cont Ops	-4.77	-4.51	-2.69	-1.71	-1.8	-2.2	-1.57	-1.91	-2.56	-0.08	-0.86	-0.94	-1.22	-1.42
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-4.26	-4.28	-1.92	-1.45	-1.37	-1.75	-1.29	-1.71	-0.88	-0.86	-0.78	-0.88	-0.85	-1.09
Free Cash Flow per Basic Share	-4.33	-4.41	-2.04	-1.53	-1.45	-2.04	-1.34	-1.76	-0.9	-0.87	-0.82	-0.96	-0.86	-1.16
Cash & Equivalents per Share	8.08	5.93	7.02	4.52	2.75	1.44	1.42	1.2	3.75	2.15	1.33	2.45	2.48	3.94
Book Value per Share	-16.07	-20.58	-8.39	-5.56	-7.01	-8.23	-7.8	-8.47	-8.88	-7.14	-8.02	-8.74	-5.63	-6.18
Tangible Book Value per Share	-38.08	-20.14	5.51	3.85	2.1	0.91	0.94	-0.08	1.25	1.15	0.46	1.14	1.99	3.49

Ocular Therapeutix, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)